The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma (Q34325005)

1 August 2017

title

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma (English)

1 reference

1 August 2017

1 reference

S Nag

1

1 reference

1 August 2017

E R Cano

2

1 reference

1 August 2017

D J Demanes

3

1 reference

1 August 2017

A A Puthawala

4

1 reference

1 August 2017

B Vikram

5

1 reference

1 August 2017

American Brachytherapy Society

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

International Journal of Radiation Oncology Biology Physics

1 August 2017

published in

1 reference

1 August 2017

volume

50

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

1190-1198

1 reference

Simplified non-looping functional loop technique for HDR brachytherapy

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Replacement of hairpin and loop implants by optimised straight line sources.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

The relationship between dental disease and radiation necrosis of the mandible

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

The potential uses of high-dose-rate brachytherapy in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Technical hints for high dose rate interstitial tongue brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Brachytherapy for recurrent head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

"Permanent iodine-125 (I-125) boost after teletherapy in primary cancers of the nasopharynx is safe and highly effective: long-term results"

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

IORT using electron beam or HDR brachytherapy for previously unirradiated head and neck cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Technique for construction of dental molds for high‐dose‐rate remote brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

A simple method of obtaining equivalent doses for use in HDR brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

High-dose reirradiation of head and neck cancer with curative intent

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Persistent carcinoma of the oropharynx and oral cavity re-treated by after-loading interstitial 192Ir implant

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Intraoperative radiotherapy in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Iodine-125 seed implantation as an adjunct to surgery in advanced recurrent squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Management of locally recurrent carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of mobile tongue and floor of mouth

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Time, Dose and Volume Factors in Interstitial Radium Implants of Carcinoma of the Oral Tongue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Analysis of time-dose factors in squamous cell carcinoma of the oral tongue and floor of mouth treated with radiation therapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Iridium-192 curietherapy for T1 and T2 epidermoid carcinomas of the floor of mouth

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Carcinoma of the mobile tongue: incidence of cervical metastases in early lesions related to method of primary treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Limited external irradiation and interstitial 192iridium implant in the treatment of squamous cell carcinoma of the tonsillar region

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Limited external beam and interstitial 192iridium irradiation in the treatment of carcinoma of the base of the tongue: A ten year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Irradiation of nasopharyngeal carcinoma: correlations with treatment factors and stage

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Nasopharyngeal carcinoma: local control by megavoltage irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Megavoltage irradiation of epithelial tumors of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Carcinoma of the nasopharynx: factors affecting prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Advanced carcinoma of the nasopharynx. 2. Pattern of failure in 256 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Treatment of Locally Recurrent Carcinoma of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Re-irradiation of laryngeal carcinoma--techniques and results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Re-irradiation of recurrent nasopharyngeal carcinoma--treatment techniques and results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Reirradiation of recurrent head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Effect of dose rate on local control and complications in the reirradiation of head and neck tumors with interstitial iridium-192

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Split course interstitial brachytherapy with a source shift: the results of a new technique for salvage irradiation in recurrent inoperable cervical lymphadenopathy greater than or equal to 4 cm diameter in 23 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in centre Alexis Vautrin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

Interstitial re-irradiation for recurrent and/or persistent head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901567-X

7 January 2021

10.1016/S0360-3016(01)01567-X

Identifiers

DOI

1 reference

1 August 2017

1 reference